Royal Bank of Canada’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $433K | Buy |
5,307
+1,444
| +37% | +$104K | ﹤0.01% | 4473 |
|
|
2026
Q1 | $263K | Sell |
3,863
-2,378
| -38% | -$168K | ﹤0.01% | 4538 |
|
|
2025
Q4 | $474K | Sell |
6,241
-92,638
| -94% | -$6.73M | ﹤0.01% | 4205 |
|
|
2025
Q3 | $6.07M | Sell |
98,879
-173,460
| -64% | -$9.03M | ﹤0.01% | 2511 |
|
|
2025
Q2 | $13.3M | Buy |
272,339
+270,503
| +14,733% | +$12.8M | ﹤0.01% | 1824 |
|
|
2025
Q1 | $93K | Sell |
1,836
-1,704
| -48% | -$85K | ﹤0.01% | 5270 |
|
|
2024
Q4 | $159K | Sell |
3,540
-4,879
| -58% | -$209K | ﹤0.01% | 5001 |
|
|
2024
Q3 | $313K | Buy |
8,419
+1,206
| +17% | +$40.4K | ﹤0.01% | 4470 |
|
|
2024
Q2 | $221K | Buy |
7,213
+4,419
| +158% | +$143K | ﹤0.01% | 4682 |
|
|
2024
Q1 | $81K | Sell |
2,794
-18,868
| -87% | -$529K | ﹤0.01% | 5307 |
|
|
2023
Q4 | $597K | Buy |
21,662
+11,787
| +119% | +$270K | ﹤0.01% | 4118 |
|
|
2023
Q3 | $222K | Buy |
9,875
+3,436
| +53% | +$128K | ﹤0.01% | 4697 |
|
|
2023
Q2 | $261K | Sell |
6,439
-3,642
| -36% | -$178K | ﹤0.01% | 4513 |
|
|
2023
Q1 | $488K | Sell |
10,081
-5,437
| -35% | -$249K | ﹤0.01% | 3884 |
|
|
2022
Q4 | $592K | Buy |
15,518
+11,239
| +263% | +$467K | ﹤0.01% | 3958 |
|
|
2022
Q3 | $215K | Sell |
4,279
-1,279
| -23% | -$62.7K | ﹤0.01% | 4711 |
|
|
2022
Q2 | $222K | Sell |
5,558
-11,884
| -68% | -$417K | ﹤0.01% | 4734 |
|
|
2022
Q1 | $651K | Sell |
17,442
-11,559
| -40% | -$445K | ﹤0.01% | 4052 |
|
|
2021
Q4 | $1.16M | Buy |
29,001
+1,954
| +7% | +$74.8K | ﹤0.01% | 3661 |
|
|
2021
Q3 | $1.01M | Sell |
27,047
-655
| -2% | -$26.9K | ﹤0.01% | 3689 |
|
|
2021
Q2 | $1.17M | Buy |
27,702
+7,421
| +37% | +$318K | ﹤0.01% | 3510 |
|
|
2021
Q1 | $961K | Buy |
20,281
+8,543
| +73% | +$507K | ﹤0.01% | 3625 |
|
|
2020
Q4 | $717K | Sell |
11,738
-737
| -6% | -$43.4K | ﹤0.01% | 3818 |
|
|
2020
Q3 | $583K | Sell |
12,475
-96
| -0.8% | -$4.73K | ﹤0.01% | 3731 |
|
|
2020
Q2 | $637K | Buy |
12,571
+2,326
| +23% | +$114K | ﹤0.01% | 3569 |
|
|
2020
Q1 | $457K | Sell |
10,245
-17,422
| -63% | -$877K | ﹤0.01% | 3696 |
|
|
2019
Q4 | $1.33M | Buy |
27,667
+1,348
| +5% | +$57.3K | ﹤0.01% | 3227 |
|
|
2019
Q3 | $890K | Sell |
26,319
-2,403
| -8% | -$105K | ﹤0.01% | 3440 |
|
|
2019
Q2 | $1.29M | Sell |
28,722
-7,614
| -21% | -$301K | ﹤0.01% | 3100 |
|
|
2019
Q1 | $1.37M | Sell |
36,336
-9,013
| -20% | -$303K | ﹤0.01% | 2959 |
|
|
2018
Q4 | $1.56M | Buy |
45,349
+6,510
| +17% | +$234K | ﹤0.01% | 2828 |
|
|
2018
Q3 | $1.82M | Buy |
38,839
+12,099
| +45% | +$501K | ﹤0.01% | 2910 |
|
|
2018
Q2 | $902K | Buy |
26,740
+26,540
| +13,270% | +$828K | ﹤0.01% | 3302 |
|
|
2018
Q1 | $5K | Sell |
200
-529
| -73% | -$13.4K | ﹤0.01% | 5932 |
|
|
2017
Q4 | $12K | Sell |
729
-10,243
| -93% | -$173K | ﹤0.01% | 5800 |
|
|
2017
Q3 | $219K | Buy |
10,972
+10,209
| +1,338% | +$200K | ﹤0.01% | 4452 |
|
|
2017
Q2 | $14K | Sell |
763
-2,920
| -79% | -$39.3K | ﹤0.01% | 5683 |
|
|
2017
Q1 | $36K | Buy |
3,683
+1,122
| +44% | +$13.6K | ﹤0.01% | 5323 |
|
|
2016
Q4 | $28K | Buy |
2,561
+519
| +25% | +$5.45K | ﹤0.01% | 5579 |
|
|
2016
Q3 | $29K | Sell |
2,042
-2,223
| -52% | -$18.1K | ﹤0.01% | 5397 |
|
|
2016
Q2 | $30K | Sell |
4,265
-4,866
| -53% | -$35.7K | ﹤0.01% | 5335 |
|
|
2016
Q1 | $60K | Sell |
9,131
-122,191
| -93% | -$2.12M | ﹤0.01% | 5023 |
|
|
2015
Q4 | $4.26M | Buy |
131,322
+114,770
| +693% | +$3.38M | ﹤0.01% | 1969 |
|
|
2015
Q3 | $442K | Sell |
16,552
-3,105
| -16% | -$133K | ﹤0.01% | 3635 |
|
|
2015
Q2 | $946K | Buy |
19,657
+1,465
| +8% | +$85.5K | ﹤0.01% | 2971 |
|
|
2015
Q1 | $1.11M | Sell |
18,192
-11,933
| -40% | -$728K | ﹤0.01% | 2780 |
|
|
2014
Q4 | $1.56M | Sell |
30,125
-16,474
| -35% | -$725K | ﹤0.01% | 2533 |
|
|
2014
Q3 | $2.05M | Buy |
46,599
+29,189
| +168% | +$913K | ﹤0.01% | 2281 |
|
|
2014
Q2 | $455K | Buy |
17,410
+8,385
| +93% | +$179K | ﹤0.01% | 3491 |
|
|
2014
Q1 | $236K | Sell |
9,025
-7,325
| -45% | -$197K | ﹤0.01% | 3969 |
|
|
2013
Q4 | $277K | Buy |
16,350
+4,995
| +44% | +$87.8K | ﹤0.01% | 3893 |
|
|
2013
Q3 | $244K | Buy |
+11,355
| New | +$197K | ﹤0.01% | 3944 |
|
Other funds holding PTCT
RI
JT
Royal Bank of Canada's PTCT Position: Q2 2026 in Review
Royal Bank of Canada increased its PTC Therapeutics (PTCT) stake by 37% in Q2 2026, buying an estimated $104K and bringing the position to 5,307 shares worth $433K. The position accounts for ﹤0.01% of the portfolio, ranked #4473.
Royal Bank of Canada first reported a position in PTCT in Q3 2013 and has held it in 52 quarters since. The position peaked at $13.3M in Q2 2025. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.
- Royal Bank of Canada held 5,307 shares of PTC Therapeutics worth $433K as of Q2 2026.
- Royal Bank of Canada bought 1,444 PTC Therapeutics shares in Q2 2026, an estimated $104K.
- PTC Therapeutics made up ﹤0.01% of Royal Bank of Canada's portfolio in Q2 2026, its #4473 holding.
- Royal Bank of Canada first reported a position in PTC Therapeutics in Q3 2013 and has held it in 52 quarters since.
- Royal Bank of Canada's PTC Therapeutics position peaked at $13.3M in Q2 2025.
- 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.
Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.